Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Report By Product (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors And Others), Therapy (Monodrug Therapy And Combination Therapy) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210343
January 2020
Report Formats:

As per this study, the Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD XXX MN by 2026 with a CAGR of X.X%.
 
Benign prostatic hyperplasia (BPH) is the medical condition typically observed in old aged men characterized by enlargement of the prostate gland resulting into squeezing of the urethra. BPH can cause problems in the urinary bladder, kidney and urinary tract. It is often treated prescribing doses of alpha-blockers, 5-alpha reductase, or combination of other drugs. For severe conditions, minimally invasive or laser therapies are also performed to treat BPH.
 
Market Dynamics
 
The rise in elderly population along with the increasing prevalence of obesity, cardiovascular diseases, and erectile dysfunction are major factors driving the market growth. The rise in awareness regarding urological diseases is contributing to the growth of BPH and prostate treatment market. Also, growing preference to advanced treatment such as TURP, TUIP, TUMT and other minimally invasive techniques are likely to foster the market growth in the following timespan.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of benign prostatic hyperplasia (BPH) and prostate treatment.
 
Market Segmentation
 
The broad benign prostatic hyperplasia (BPH) and prostate treatment market has been sub-grouped into product and therapy. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Alpha Blockers
  • 5-Alpha Reductase Inhibitor
  • Phosphodiesterase-5 Inhibitors
  • Others
 
By Therapy
  • Monodrug Therapy
  • Combination Therapy
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for benign prostatic hyperplasia (BPH) and prostate treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Revenue (USD MN)
 
Europe Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the benign prostatic hyperplasia (BPH) and prostate treatment market include Abbott Laboratories, Allergan plc, Astellas Pharma Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Limited. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       2.2. Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Snapshot
 
3 . BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.3. Market Restraints of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.4. Opportunities of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.5. Trends of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.6. Porter’s Five Force Analysis of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market
       3.7. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Therapy
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Value Chain Analysis
       4.2. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product
       5.3 Market Analysis of Alpha Blockers by Regions
       5.4 Market Analysis of 5-Alpha Reductase Inhibitor by Regions
       5.5 Market Analysis of Phosphodiesterase-5 Inhibitors by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY THERAPY
       6.1 Overview by Therapy
       6.2 Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy
       6.3 Market Analysis of Monodrug Therapy by Regions
       6.4 Market Analysis of Combination Therapy by Regions
 
7 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.3.3. North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.4.3. Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.5.3. Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.6.3. Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Market Segment
           7.7.3. Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT COMPANIES
       8.1. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Abbott Laboratories
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Allergan plc
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Astellas Pharma Inc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Boehringer Ingelheim Pharma GmbH & Co. KG
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Eli Lilly and Company
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. GlaxoSmithKline plc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Merck & Co., Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Pfizer Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Sanofi
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Teva Pharmaceutical Industries Limited
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Alpha Blockers by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in 5-Alpha Reductase Inhibitor by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Phosphodiesterase-5 Inhibitors by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Others by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Monodrug Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Combination Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Geography (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • United State Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • United State Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of North America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • United Kingdom Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • United Kingdom Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • France Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • France Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Germany Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Germany Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Europe Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • China Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • China Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Japan Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Japan Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • India Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • India Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • Brazil Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Brazil Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Rest of Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Rest of Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Country (USD MN)
  • Middle East Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Middle East Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Estimate by Therapy (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Product (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Alpha Blockers by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in 5-Alpha Reductase Inhibitor by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Phosphodiesterase-5 Inhibitors by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Others by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis by Therapy (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Monodrug Therapy by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Analysis in Combination Therapy by Geography (USD MN)
  • Latin America Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Revenue
  • Middle East & Africa Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Revenue
  • Recent Development in Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact

The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.